Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational studySalvatore Petta, S. Fagiuoli, Andrea Antinori et al.|The Lancet. Gastroenterology & hepatology|2017Cited by 19
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experienceAntonio Ascione, Vincenzo Messina, Cleo Study Group et al.|World Journal of Hepatology|2016Cited by 9
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosisAntonio Ascione, N. Caporaso, M. De Luca et al.|Infection|2018Cited by 8